Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds UBS Upgrades CureVac to Buy, Announces $18 Price Target

UBS Upgrades CureVac to Buy, Announces $18 Price Target

UBS analyst Eliana Merle upgrades CureVac (NASDAQ:CVAC) from Neutral to Buy and announces $18 price target.

byBenzinga Newsdesk

January 19, 2023

1 minute read

UBS analyst Eliana Merle upgrades CureVac (NASDAQ:CVAC) from Neutral to Buy and announces $18 price target.

BREAKING: Solana Ecosystem Hack Sees $580M Drained From Private Wallets…So Far

By Samyuktha Sriram

August 2, 10:12 PM

The Solana (CRYPTO: SOL) blockchain appears to be facing an ongoing exploit that has compromised users' private wallets across the ecosystem.

SOL

Jim Cramer ‘Can’t Be A Fan’ Of Company ‘That’s Losing That Much Money’ After CEO’s Profit Assurance

By Lisa Levin

Yesterday, 9:11 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said SolarEdge Technologies, Inc. (NASDAQ: SEDG) is "interesting. It’s down a lot…I really want you to take a hard look at First Solar, Inc.

CELH

Analyst Ratings

What 6 Analyst Ratings Have To Say About Triumph Financial

By Benzinga Insights

April 5, 1:01 PM

Analysts have provided the following ratings for Triumph Financial (NASDAQ:TFIN) within the last quarter: Bullish Somewhat Bullish Indifferent…

TFIN

News
Tech

Cerebral Under Fire For Sharing Sensitive Health Data Of 3.1M US Patients With Google, Meta, TikTok

By Ananya Gairola

March 13, 5:45 AM

Health startup Cerebral is facing intense scrutiny and backlash after it inadvertently shared private data with tech giants…

GOOG

UBS Upgrades CureVac to Buy, Announces $18 Price Target

Related Posts

BREAKING: Solana Ecosystem Hack Sees $580M Drained From Private Wallets…So Far

Jim Cramer ‘Can’t Be A Fan’ Of Company ‘That’s Losing That Much Money’ After CEO’s Profit Assurance

What 6 Analyst Ratings Have To Say About Triumph Financial

Cerebral Under Fire For Sharing Sensitive Health Data Of 3.1M US Patients With Google, Meta, TikTok